StopDown
Partnership · 14 August 2026Redcliffe LabsOmnichannel diagnostic service providerredcliffelabs.com ↗

Redcliffe Labs partners with Skyroot Aerospace for space diagnostics

By · Editor ·

  • Redcliffe Labs is an omnichannel diagnostic service provider with labs across 220+ cities
  • It has partnered with Skyroot Aerospace to test dry diagnostic reagents in Low Earth Orbit for 90 days
  • The experiment could help develop diagnostic products for space missions and remote areas with limited lab infrastructure

What happened

  • Redcliffe Labs and Skyroot Aerospace have partnered to test diagnostic reagents in space.
  • The first experiment, named DRIFT-1, will place Redcliffe's dry diagnostic reagents in Low Earth Orbit for 90 days.
  • The performance of the space-exposed reagents will be compared with an identical control sample maintained on Earth.
  • The experiment aims to examine how the space environment affects reagent stability and performance.
  • The initiative is expected to generate flight data for diagnostic technologies for space missions and challenging Earth environments.
  • Findings could help develop diagnostic products for locations with limited lab infrastructure or cold-chain facilities.
  • Potential applications include astronaut healthcare, life sciences, microgravity research, and point-of-care diagnostics for human spaceflight programmes such as Gaganyaan and Bharatiya Antariksh Station.
  • The statement did not disclose the launch timeline, rocket or spacecraft, number or types of reagents, or financial terms of the partnership.

Why it matters

  • Redcliffe Labs recently divested its fertility services business Crysta IVF to focus on diagnostics.
  • Skyroot Aerospace conducted the first orbital rocket launch by an Indian private company in July 2026.
  • The partnership could open new applications for diagnostics in space and remote areas.

The business

  • Redcliffe Labs is an omnichannel diagnostic service provider offering pathology and diagnostic services through labs, collection centres, and home sample collection.
  • It operates across more than 220 cities and offers over 3,600 diagnostic tests.
  • The company has 80+ self-owned certified labs, 2,000+ collection centres, and 1,500+ trained phlebotomists.
  • It has touched over 1 crore lives.

The founders

Aditya Kandoi

Founder & CEO
in

Dheeraj Jain

Chairman & Co-Founder

Ashish Dubey

Co-Founder

In numbers

220+Cities of operation
3,600+Diagnostic tests offered
1 Crore+Lives touched
80+Self-owned labs
2,000+Collection centres
1,500+Trained phlebotomists
$115 MnTotal funding raised

What happens next

  • The partnership aims to generate flight data for diagnostic technologies for space missions and challenging Earth environments.
  • Findings could lead to diagnostic products for locations with limited lab infrastructure or cold-chain facilities.
  • Potential applications include astronaut healthcare, life sciences, microgravity research, and point-of-care diagnostics for human spaceflight programmes including Gaganyaan and Bharatiya Antariksh Station.

Earlier rounds

  • September 2024 · Series C · $42 Mn · led by Denmark's Investment Fund for Developing Countries

Words to know

Low Earth Orbit
An orbit around Earth at an altitude between 160 and 2,000 kilometres, commonly used for satellites and the International Space Station.
Dry diagnostic reagents
Reagents that are stored in a dry, stable form and can be rehydrated for use, making them easier to transport and store without cold chains.
Gaganyaan
India's human spaceflight programme led by ISRO, aiming to send astronauts to Low Earth Orbit.
Bharatiya Antariksh Station
India's planned space station, expected to be operational by the 2030s.

The numbers around it

Redcliffe Labs has 4 funding rounds in StopDown's archive, $115 Mn raised in all.

#The numbers around it
WhenRoundAmountLed by
17 September 2024Series C$42MIFU (Denmark's Investment Fund for Developing Countries)
13 August 2023growth$80 million
29 September 2022Series B$100-125 million
6 May 2022Series B$61MLeapFrog Investments

Healthcare & Life Sciences in August 2026: 10 rounds with a disclosed amount, $139 million in all; the biggest was Biodeal Pharmaceuticals (₹385 crore). Every sector this year →

Other articles talking about it

Read it as a card in the app

Everything on Redcliffe Labs → · All startup news on 14 August 2026 →

Is this Redcliffe Labs? Get your “Featured on StopDown” badge →